Avidity Biosciences, Inc. ($RNAM)
Filing Information
| Accession Number | 0001193125-26-082261 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 27, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
547,865
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 27, 2026 | Sale to Issuer | 150,365 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 25,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 66,500 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 96,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 72,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 88,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Sale to Issuer | 50,000 | โ | โ | 0 | Direct | โ | View Details |